Perioperative management and neuraxial analgesia in women with factor XI deficiency (

Authors: Flaujac, C., Faille, D., Lavenu-Bombled, C., Drillaud, N., Lasne, D., Billoir, P., Desconclois, C., Touzet, L., Lebreton, A., Diaz-Cau, I., d’Oiron, R., Giansily-Blaizot, M., Wibaut, B., Beurrier, P., Volot, F., Rugeri, L., Roussel-Robert, V., de Raucourt, E.

Source: In Research and Practice in Thrombosis and Haemostasis May 2024 8(4)

Évaluation de l’impact budgétaire de l’introduction d’un traitement par émicizumab chez des patients atteints d’hémophilie A sévère congénitale sans inhibiteur

Alternate Title: Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor (English)

Authors: Oka, G., Pieragostini, R., Roussel-Robert, V., Paubel, P., Degrassat-Theas, A., Lopez, I.

Source: In Annales Pharmaceutiques Françaises May 2023 81(3):529-537

The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study)

Authors: le Doré S, Grinda N, Ferré E, Roussel-Robert V, Frotscher B, Chamouni P, Meunier S, Bayart S, Dolimier E, Truong-Berthoz F, de Raucourt E

Source: Journal of Blood Medicine, Vol Volume 12, Pp 133-138 (2021)

Subject Terms: hemarthrosis, hemophilia, knee joint, patient education as topic, therapeutic education, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://www.dovepress.com/the-hemarthrosis-simulating-knee-model-a-useful-tool-for-individualize-peer-reviewed-article-JBM; https://doaj.org/toc/1179-2736

Access URL: https://doaj.org/article/bb61008b2bc04845aeb40a1a256df30e

OC 43.3 Surgery in People with Hemophilia a Receiving Emicizumab Prophylaxis: Real-World Experience from a Single French Reference Center of Hemophilia

Authors: Brakta, C., Stieltjes, N., Combe, S., Ounnoughene, N., Duchemin, J., Capdevila, L., Goubeau, L., Fontenay, M., Roussel Robert, V., Proulle, V.

Source: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2

Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling

Authors: Jourdy, Y., Chatron, N., Fretigny, M., Carage, M. L., Chambost, H., Claeyssens-Donadel, S., Roussel-Robert, V., Negrier, C., Sanlaville, D., Vinciguerra, C.

Source: HAEMOPHILIA -OXFORD-. 23(4):e316-e323

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN385324375&indx=1&recIds=ETOCRN385324375

Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors
Haemostasis management

Authors: d Oiron, R., Volot, F., Reynaud, J., Peerlinck, K., Goudemand, J., Guerois, C., Rothschild, C., Chambost, H., Borel-Derlon, A., Roussel-Robert, V.

Source: SEMINARS IN HEMATOLOGY. 43(1):S3-S9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN058813450&indx=1&recIds=ETOCCN058813450

Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience

Authors: Rossi, B., Blanche, P., Roussel-Robert, V., Berezn, A., Combe, S., Coppo, P., Guillevin, L., Le Jeunne, C., Mouthon, L., Ounnoughene, N.

Source: HAEMOPHILIA -OXFORD-. 22(4):e338-e341

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN380972825&indx=1&recIds=ETOCRN380972825

Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events

Authors: Raucourt, E., Roussel-Robert, V., Zetterberg, E.

Source: EUROPEAN JOURNAL OF HAEMATOLOGY. 94(SUPP/77):23-29

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN365613174&indx=1&recIds=ETOCRN365613174

Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A

Authors: Calvez, T., Chambost, H., Claeyssens-Donadel, S., d Oiron, R., Goulet, V., Guillet, B., Heritier, V., Milien, V., Rothschild, C., Roussel-Robert, V.

Source: BLOOD -NEW YORK-. 124(23):3398-3408

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN364410601&indx=1&recIds=ETOCRN364410601

Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost - the `Statut Orthopedique des Patients Hemophiles' avec Inhibiteur study

Authors: Stieltjes, N., Torchet, M.F., Misrahi, L., Roussel-Robert, V., Lambert, T., Guerois, C., Bertrand, M.A., Briquel, M.E., Borel-Derlon, A., Dirat, G.

Source: BLOOD COAGULATION AND FIBRINOLYSIS. 20(1):4-11

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN243151260&indx=1&recIds=ETOCRN243151260

Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients

Authors: BOREL-DERLON, A., FEDERICI, A. B., ROUSSEL-ROBERT, V., GOUDEMAND, J., LEE, C. A., SCHARRER, I., ROTHSCHILD, C., BERNTORP, E., HENRIET, C., TELLIER, Z.

Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 5(6):1115-1124

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN209070843&indx=1&recIds=ETOCRN209070843

Dental extractions in children with congenital coagulation disorders: therapeutic protocol and results

Authors: Brahim, A. K., Stieltjes, N., Roussel-Robert, V., Yung, F., Ginisty, D.

Source: REVUE DE STOMATOLOGIE ET DE CHIRURGIE MAXILLO- FACIALE. 107(5):331-337

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN198268833&indx=1&recIds=ETOCRN198268833

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases

Authors: Berezne, A., Stieltjes, N., Le-Guern, V., Teixeira, L., Billy, C., Roussel-Robert, V., Flaujac, C., Horellou, M. H., Guillevin, L., Mouthon, L.

Source: TRANSFUSION MEDICINE. 16(3):209-212

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN188488583&indx=1&recIds=ETOCRN188488583

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience

Authors: Stieltjes, N., Altisent, C., Auerswald, G., Negrier, C., Pouzol, P., Reynaud, J., Roussel-Robert, V., Savidge, G. F., Villar, A., Schulman, S.

Source: HAEMOPHILIA -OXFORD-. 10(5):452-458

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN155198007&indx=1&recIds=ETOCRN155198007

Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus

Authors: Stieltjes, N., Ounnoughene, N., Sava, E., Paugy, P., Roussel-Robert, V., Rosenberg, A. R., Terris, B., Salmon-Ceron, D., Sogni, P.

Source: BRITISH JOURNAL OF HAEMATOLOGY. 125(6):769-776

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN150640713&indx=1&recIds=ETOCRN150640713

Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A

Authors: Misra, N., Bayry, J., Pashov, A., Kaveri, S. V., d Oiron, R., Stieltjes, N., Roussel-Robert, V., Kazatchkine, M. D., Boyer, O., Lacroix-Desmazes, S.

Source: THROMBOSIS AND HAEMOSTASIS -STUTTGART-. 90(5):813-822

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN140214061&indx=1&recIds=ETOCRN140214061

Extractions dentaires chez l’enfant présentant une maladie hémorragique constitutionnelle : protocole thérapeutique et résultats

Alternate Title: Dental extractions in children with congenital coagulation disorders : therapeutic protocol and results (English)

Authors: Kaddour Brahim, A., Stieltjes, N., Roussel-Robert, V., Yung, F., Ginisty, D.

Source: In Revue de Stomatologie et de Chirurgie Maxillo-faciale 2006 107(5):331-337

Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?

Authors: Barr, A., Dranic, J., Flaujac, C., Roussel-Robert, V., Stieltjes, N., Combe-Marzelle, S., Coriat, R., Horellou, M.

Source: HAEMOPHILIA -OXFORD-. 22(4):e347-e348

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN380972853&indx=1&recIds=ETOCRN380972853

This result is not displayed to guests.
Login for full access.

Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients

Authors: Roussel-Robert, V., Torchet, M. F., Legrand, F., Rothschild, C., Stieltjes, N.

Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 1(11):2450-2451

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN140378754&indx=1&recIds=ETOCRN140378754